ViBA

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy.

Margara F, Psaras Y, Wang ZJ · Scientific reports · 2022 · Article

10.1038/s41598-022-26889-2

Verified evidence

Model scenario comparison

83493ebf-8a37-5668-aff8-5b942b3d3c08
Cardiac contraction and ventricular function

Prediction source Version of record · PDF page(s) 5

Study 186530e5-5ba1-5550-8f55-299662acfeb6 · Prediction record (JSON)

Prediction fields

Concrete comparator
variant hypertrophic-cardiomyopathy virtual ventricles versus the virtual healthy-ventricle reference for end-systolic volume · PDF page(s) 5
Endpoint
left_ventricular_end_systolic_volume · PDF page(s) 5
Family
cardiac_function · PDF page(s) 5
Measured variable
left_ventricular_end_systolic_volume · PDF page(s) 5
Measurement role
physiological_outcome · PDF page(s) 5
Reference type
simulated_against_baseline · PDF page(s) 5
Role
simulated_output · PDF page(s) 5
Scenario
within_model_scenario_comparison · PDF page(s) 5

Hypertrophic cardiomyopathy cellular model and simulation inputs · Corresponding authors · Study model code and Alya simulation inputs · Prediction-linked resource · PDF page 14 · Restricted availability reported by the authors · Curated resource record